Genetic Factors of Erectile Dysfunction Degree and Response to Tadalafil Treatment in Patients With Diabetes

PHASE3RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 17, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Erectile Dysfunction With Diabetes Mellitus
Interventions
DRUG

Tadalafil 5mg

We will include in the study 90 patients with diabetes and erectile dysfunction. We will use the IIEF-5 questionnaire to confirm the diagnosis of erectile dysfunction. Patients between the ages of 40 and 65 who score 21 points or less on the IIEF-5 scale will be included in the study. Each patient will receive drug tadalafil 5 mg every day for three months.

Trial Locations (1)

1000

RECRUITING

University Medical Centre Ljubljana, Ljubljana

All Listed Sponsors
lead

University Medical Centre Ljubljana

OTHER